SCHEMBL7410769

SCHEMBL7410769

Cc1ccc(S(=O)(=O)NC(CNS(=O)(=O)c2cccc3ccccc23)C(=O)NO)cc1

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.61
MMP7 P09237 4/20 0.53
MMP9 P14780 3/20 0.52
MMP10 P09238 1/20 0.52
MMP13 P45452 2/20 0.51
ALDH1A1 P00352 2/20 0.46
MMP2 P08253 2/20 0.46
BMP1 P13497 2/20 0.45
SLC6A9 P48067 5/20 0.44
ADAM17 P78536 2/20 0.44
MMP1 P03956 1/20 0.44
MMP14 P50281 1/20 0.44
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419448 0.90 MMP7 (0.58) NPY5RMMP7MMP9MMP10ALDH1A1
SCHEMBL7413636 0.89 MMP7 (0.53) NPY5RMMP7MMP9MMP10MMP2
SCHEMBL7410576 0.89 MMP7 (0.65) NPY5RMMP7MMP9MMP10ALDH1A1
SCHEMBL7416850 0.89 MMP7 (0.58) NPY5RMMP7MMP9MMP10MMP13
SCHEMBL7411514 0.85 MMP7 (0.51) NPY5RMMP7MMP9MMP10SLC6A9
SCHEMBL7411422 0.85 MMP7 (0.58) NPY5RMMP7MMP9MMP10ALDH1A1
SCHEMBL7408520 0.85 MMP7 (0.53) NPY5RMMP7MMP9MMP10MMP2
SCHEMBL7414985 0.85 MMP7 (0.58) NPY5RMMP7MMP9MMP10MMP13
SCHEMBL8006415 0.84 MMP7 (0.70) MMP7MMP9MMP10MMP13ALDH1A1
SCHEMBL7416827 0.83 MMP7 (0.51) NPY5RMMP7MMP9MMP10SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed